Clinical Trial Liability Insurance in California

California at a glance

Primary regulator

California Department of Insurance

Oversees insurer licensing and policy filings for organizations operating in the state.

State consent statute

Protection of Human Subjects in Medical Experimentation Act

Sets disclosure requirements for research consent forms beyond federal common-rule obligations.

Damages framework

MICRA cap raised and indexed to inflation under AB 35 (2022)

The historically fixed noneconomic damages cap now escalates annually; confirm the current figure with counsel.

Privacy exposure

Confidentiality of Medical Information Act and California Consumer Privacy Act

Both layer state-specific breach-notification duties on top of federal HIPAA requirements.

A dedicated state research-consent statute

California's Protection of Human Subjects in Medical Experimentation Act sets specific informed-consent requirements for experimental research that go beyond federal common-rule obligations, including detailed disclosure elements a consent form must contain and criminal penalties for certain violations involving experimentation without consent. This means a California consent form drafted only to satisfy FDA and IRB requirements may still fall short of the state statute's more prescriptive disclosure list, and sites should confirm their consent templates were reviewed against the state act specifically, not only against federal common-rule checklists.

MICRA's cap after AB 35

California's Medical Injury Compensation Reform Act long capped noneconomic damages in medical-malpractice claims at a fixed figure that had not changed since the 1970s, until AB 35 amended MICRA in 2022 to raise the cap and index it to annual increases going forward, with a higher cap for wrongful-death claims. Sponsors should confirm the currently applicable cap figures with counsel each policy period, since the statute now escalates annually rather than sitting at a fixed historical number.

Biotech and academic research density

California's trial activity spans the Bay Area's biotechnology and device-development cluster, Los Angeles's academic medical centers, and San Diego's life-sciences corridor, giving the state one of the country's highest concentrations of early-phase and device trials. That density means California sponsors often manage a larger portfolio of simultaneous protocols than in other states, raising the practical importance of standardized indemnity and additional-insured language across a large number of site agreements.

Privacy law layered on federal HIPAA

California's Confidentiality of Medical Information Act and the California Consumer Privacy Act both impose obligations on research data beyond HIPAA's federal baseline, and a data breach involving trial participant records in California can trigger notification and liability exposure under both state statutes simultaneously. Cyber coverage limits for California operations should be sized with this layered exposure in mind rather than assuming HIPAA compliance alone is sufficient.

Coordinating the program

A California program typically layers trial-specific liability with products/completed-operations coverage, medical professional liability for site clinicians, and cyber coverage sized for the state's layered privacy statutes. Confirm current MICRA cap figures and state consent-act compliance with counsel before finalizing limits.

Who we write this for in California

Clinical trial liability FAQs for California